Delivery Order SPE2DB20D1100-SPE2DB25FD2V2

Award Date 7/7/25
Potential Completion Date 7/8/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,291.66 and a period of performance through March 3, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical supply, with a ceiling value of $23,557.00 and a completion date of June 5, 2025. The contract is a Firm Fixed Price arrangement and is not set aside for any specific business size or type. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $3,168.87 and a period of performance through June 13, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $45,392.01 and a completion date of July 8, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,287.74 and a performance period ending on July 2, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $15,235.12 and a period of performance through June 24, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,157.67 and a period of performance ending on July 3, 2025. The contract is a firm fixed-price delivery order, indicating that AmerisourceBergen will provide the specified pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $1,596.91. The order is for ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a period of performance through June 24, 2025. The contract is a firm fixed price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $5,746.38 and a period of performance through July 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $12,420.08 and a period of performance through May 19, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation, indicating open competition. This award...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FD2V2
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,962.87 and a period of performance through July 8, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 10/6/25, 12:49 PM